Abstract:You have accessJournal of UrologyBladder Cancer: Basic Research I1 Apr 2015MP36-01 MITOCHONDRIAL DNA CONTENT AS RISK FACTOR FOR BLADDER CANCER AND ITS ASSOCIATION WITH MITOCHONDRIAL DNA POLYMORPHISMS Stephen Williams, Yanquing Ye, Maosheng Huang, David Cheng, Ashish Kamat, Xia Pu, Colin Dinney, and Xifeng Wu Stephen WilliamsStephen Williams More articles by this author , Yanquing YeYanquing Ye More articles by this author , Maosheng HuangMaosheng Huang More articles by this author , David ChengDavid Cheng More articles by this author , Ashish KamatAshish Kamat More articles by this author , Xia PuXia Pu More articles by this author , Colin DinneyColin Dinney More articles by this author , and Xifeng WuXifeng Wu More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2015.02.729AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Mitochondrial DNA (mtDNA) content (also termed mtDNA copy number) has been shown to be associated with cancer susceptibility, however, whether the mtDNA content contribute to bladder cancer risk and its association with mtDNA polymorphisms in modulating bladder cancer risk remains to be determined. The association between mtDNA content as well as polymorphisms in peripheral blood leukocytes and risk of bladder cancer has not been reported. METHODS We identified 926 bladder cancer patients and compared these to 926 healthy-controls frequency matched on age, gender, and ethnicity enrolled in an ongoing bladder cancer study at the MD Anderson Cancer Center. Multivariable logistic regression analysis was used to examine the association between mtDNA content in peripheral blood lymphocytes and the risk of bladder cancer. RESULTS Patients diagnosed with bladder cancer had significantly decreased mtDNA content when compared to control subjects (median: 0.98 vs. 1.04, p<0.001). Low mtDNA content (ie, less than the median in control subjects) was associated with a statistically significant increased risk of bladder cancer, when compared with high mtDNA content (Odds Ratio (OR) = 1.37, 95% CI = 1.13 to 1.66, p<0.001). In a trend analysis, a statistically significant dose–response relationship was detected between lower mtDNA content and increasing risk of bladder cancer (P for trend <0.001). When stratified by host characteristics, advanced age (>65 years), male/female sex and positive smoking history were all significantly associated with low mtDNA content and increased risk of bladder cancer. We identified two unique mtDNA polymorphisms significantly associated with risk of bladder cancer: mitot10464c (OR=1.39 95%CI: 1.00-1.93, p=0.048) and mitoa4918g (OR=1.40, 95% CI: 1.00-1.95, p=0.049). Analysis of the joint effect of low mtDNA content and unfavorable mtDNA polymorphisms revealed a 2.5 fold increased risk of bladder cancer (OR=2.50, 95% CI: 1.60-3.94, p<0.001). Significant interaction was observed between mitoa4918g and mtDNA content (p for interaction = 0.028). CONCLUSIONS Low mtDNA content appears to be associated with increased risk of bladder cancer. We identified new susceptibility mtDNA alleles for bladder cancer risk that require further investigation into the biological underpinnings of bladder carcinogenesis. © 2015 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 193Issue 4SApril 2015Page: e428 Advertisement Copyright & Permissions© 2015 by American Urological Association Education and Research, Inc.MetricsAuthor Information Stephen Williams More articles by this author Yanquing Ye More articles by this author Maosheng Huang More articles by this author David Cheng More articles by this author Ashish Kamat More articles by this author Xia Pu More articles by this author Colin Dinney More articles by this author Xifeng Wu More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...

Lower Mitochondrial Dna Copy Number in Peripheral Blood Leukocytes Increases the Risk of Endometrial Cancer

Association of Leukocyte Telomere Length in Peripheral Blood Leukocytes with Endometrial Cancer Risk in Caucasian Americans

Abstract 4320: Mitochondrial DNA Copy Number in Peripheral Blood and the Risk of Clear-Cell Renal Cell Carcinoma: Effect of Age, Gender, Smoking, and History of Hypertension

Increased leukocyte mitochondrial DNA copy number is associated with oral premalignant lesions: an epidemiology study.

The Association Between Metabolic Abnormality and Endometrial Cancer: a Large Case-Control Study in China.

Reduced Mitochondrial Dna Copy Number in Peripheral Blood Leukocytes Increases the Risk of Soft Tissue Sarcoma

Mitochondrial DNA Copy Number in Peripheral Blood Leukocytes and the Risk of Clear Cell Renal Cell Carcinoma.

Serum Leptin, Adiponectin and Endometrial Cancer Risk in Chinese Women

Associations of Blood Mitochondrial DNA Copy Number with Social-Demographics and Cancer Risk: Results from the Mano-A-Mano Mexican American Cohort

Association between mitochondrial DNA content in leukocytes and colorectal cancer risk

Abstract 879: Mitochondrial DNA Content and Its Association with Lung Cancer Risk and Clinical Outcomes

Mitochondrial DNA Copy Number in Peripheral Blood Leukocytes and the Aggressiveness of Localized Prostate Cancer.

Mitochondrial DNA copy number and cancer risks: A comprehensive Mendelian randomization analysis

Abstract 3658: the Association of Mitochondrial DNA Content with Bladder Cancer Risk and Outcome

MP36-01 MITOCHONDRIAL DNA CONTENT AS RISK FACTOR FOR BLADDER CANCER AND ITS ASSOCIATION WITH MITOCHONDRIAL DNA POLYMORPHISMS

Abstract 4509: Mitochondrial DNA Copy Number is Inversely Associated with Overall Survival in Non-Small Cell Lung Cancer

Abstract 3056: Mitochondrial DNA Copy Number and Risk of Second Primary Tumors in Long-Term Breast Cancer Survivors

Association Between Whole Blood-Derived Mitochondrial DNA Copy Number, Low-Density Lipoprotein Cholesterol, and Cardiovascular Disease Risk

No association between mitochondrial DNA copy number and colorectal adenomas

Mitochondrial DNA copy number in peripheral blood in polycystic ovary syndrome

Germline copy number variants and endometrial cancer risk